Issue link: https://www.e-digitaleditions.com/i/1544305
40 April 2026 Inhalation Development of sustainable respiratory drug delivery solutions Collaborating for two decades with pharmaceutical companies, CDMOs and start-ups on the develop- ment of DPIs, pMDIs and nebulizers. Gaining early insights into how a medical device will meet the needs of patients and caregivers is crucial to maintaining development timelines. Prior PLM Medical combines advanced computational simulations with a range of visualization techniques and rigorous physical testing to ensure that only the most viable concepts advance. (See the video linked below.) is targeted approach focuses resources and shortens the design cycle. Dis- cover how we can support you to de-risk the devel- opment process, accelerate your time to market and deliver for patients. Prior PLM Medical Ireland: +353 71 9620980 info@priors.com www.priors.com Inhaled and nasal drug delivery systems RxPack is a global leader in pharmaceutical dis- pensing solutions and inhaled nasal drug delivery systems. Specializing in pMDIs, RxPack offers a comprehensive valve portfolio for solutions and sus- pensions, for single or double-stage filling. e com- pany supports its customers in navigating complex product development changes and the transition from the existing propellants to the new HFA-152a and HFO-1234ze(E) gases. RxPack partners with Coster's Machinery Division for the provision of lab- scale and high-speed filling lines. RxPack S.r.l. Italy: +39 034118960 info@rxpack.it www.rxpack.eu DPI and nasal delivery formulation, device and manufacturing Hovione provides specialist expertise and leadership in particle engineering and formulation development to ensure that your inhalation and nasal therapies are engineered for success from start to finish. Fully inte- grated in one site, Hovione offers simple, patented and globally competitive dry powder inhalers— disposable, capsule, blister, large dose and high performance DPIs—which are available for fully integrated, turnkey development with formulation and for licensing. Expanding our inhalation offering, Hovione provides advanced nasal powder delivery devices, designed for local, systemic and nose-to- brain applications. Hovione—Delivering solutions, every breath of the way. Hovione Portugal: +351 21 982 9000 hovione.com/contact-us www.hovione.com pMDI technology and product development i2c Pharmaceutical Services is an experienced service provider for the development of pharmaceutical for- mulations. Respitab is a propellant dispersible tablet that eliminates the need for complex mixing processes used in standard pressurized metered dose inhaler (pMDI) manufacturing. is patented, innovative platform enables transition to low global warming potential (GWP) pMDIs for a range of active pharma- ceutical ingredients (APIs) and combination products. Respitab can provide a cost-effective approach for new chemical entity (NCE) and generic pMDI products, simplifying manufacturing processes for low GWP propellants. Respitab can generate highly efficient aerosol properties and dose uniformity characteristics, reduce waste/API losses and facilitate scalability. i2c Pharma Services UK: +44 2920 757865 info@i2cpharm.co.uk www.i2cPharm.co.uk

